HI
FMED icon

Harbour Investments’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Harbour Investments’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41
Closed -$993 – 3253
2023
Q4 		$993 Hold
41
– – ﹤0.01% 2826
2023
Q3 		$907 Hold
41
– – ﹤0.01% 2723
2023
Q2 		$1.03K Buy
+41
New +$1.03K ﹤0.01% 2694

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Investments's FMED Position: Q1 2024 in Review

Harbour Investments sold out of Fidelity Disruptive Medicine ETF (FMED) in Q1 2024, closing a stake of 41 shares — an estimated $993 sold.

Harbour Investments first reported a position in FMED in Q2 2023 and held it in 3 quarters. The position peaked at $1.03K in Q2 2023. 8 funds tracked by Wall St. Rank hold FMED as of Q1 2024.

  • Harbour Investments reported no remaining Fidelity Disruptive Medicine ETF position as of Q1 2024 after selling out during the quarter.
  • Harbour Investments sold 41 Fidelity Disruptive Medicine ETF shares in Q1 2024, an estimated $993.
  • Harbour Investments first reported a position in Fidelity Disruptive Medicine ETF in Q2 2023 and held it in 3 quarters.
  • Harbour Investments's Fidelity Disruptive Medicine ETF position peaked at $1.03K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2024.

Based on Harbour Investments's 13F filing for Q1 2024, filed 22 Jul 2024.